by Jessica | Dec 15, 2021
by Jessica | Oct 17, 2021
Plexium has landed $28 million in Series A financing to launch a proprietary platform that can identify novel therapeutics that can modulate protein degradation to treat cancer and neurodegenerative diseases. The platform technology, dubbed DELPhe, takes advantage of...